(SNS9O.BA)

Compare

99,400.00

0.00

(0.00%)

At close: March 11 at 4:52:21 PM GMT-3

Meta is reportedly testing in-house chips for AI training

Meta is reportedly testing an in-house chip for training AI systems, a part of a strategy to reduce its reliance on hardware makers like Nvidia. According to Reuters, Meta's chip, which is designed to handle AI-specific workloads, was manufactured in partnership with Taiwan-based firm TSMC. The company is piloting a "small deployment" of the chip and plans to scale up production if the test is successful. Meta has deployed custom AI chips before, but only to run models — not train them. As Reute

TechCrunch 10 hours ago

NVDA
Teradyne stock plummeting after updating its guidance

Teradyne (TER) stock dropped by as much as 17% ahead of Tuesday's session close after the automated test equipment (ATE) manufacturer revised its guidance lower. Julie Hyman and Josh Lipton report more on Teradayne's stock moves. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.

Yahoo Finance Video 13 hours ago

TER
Kohl's stock plummets as sales drop, guidance widely misses estimates amid turnaround efforts

The department store is attempting another turnaround.

Yahoo Finance 17 hours ago

KSS

M
Kohl's stock plunging on its cautious 2025 outlook: 3 takeaways

Kohl's (KSS) shares plunge by over 16% Tuesday morning following the department store chain's mixed fourth quarter earnings results and full-year guidance that anticipates a 4 to 6% comparable sales decline in 2025. Yahoo Finance senior retail reporter Brooke DiPalma joins the Morning Brief team in analyzing the biggest takeaways from Kohl's earnings call, the first to feature new CEO Ashley Buchanan. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.

Yahoo Finance Video 19 hours ago

KSS
Should You Buy Advanced Micro Devices (AMD) Stock After Its 51% Drop?

The stock market is in the midst of a sell-off right now, with the Nasdaq Composite down more than 9% from its recent all-time high. AMD supplies some of the world's best chips for a range of different applications, including a lineup of graphics processing units (GPUs) for the data center, which are designed specifically for artificial intelligence (AI) development. In fact, they are quickly catching up to Nvidia's (NASDAQ: NVDA) industry-leading GPUs in terms of performance.

Motley Fool 20 minutes ago

AMD

NVDA

MSFT
Nvidia Is Down 26% From Its All-Time High -- Here's How Far It Can Fall, Based on Historic Precedent

Though history can't concretely predict the future, it does have an uncanny track record of rhyming on Wall Street, more often than not.

Motley Fool 27 minutes ago

NVDA

MSFT
The Nasdaq Just Hit Correction Territory: 2 Brilliant AI Stocks to Buy Now and Hold Forever

Warren Buffett has often endorsed a contrarian investment strategy. Uncertainty surrounding the Trump administration's trade policies has caused the technology-focused Nasdaq Composite (NASDAQINDEX: ^IXIC) to fall more than 10% from its recent high. Investors should follow Buffett's advice and treat the drawdown as a buying opportunity.

Motley Fool 57 minutes ago

NVDA

COMP

AMZN
Puma Drops After Predicting a Tough Year for Sneaker Sales

(Bloomberg) -- Puma SE shares plunged after the sneaker maker disappointed investors for the second time in seven weeks with softer-than-expected results and forecast another year of slow growth.Most Read from BloombergNYC Congestion Pricing Toll Gains Support Among City ResidentsTrump DEI Purge Hits Affordable Housing GroupsElectric Construction Equipment Promises a Quiet RevolutionWhere New York City's Zoning Reform Will Add HousingOpen Philanthropy Launches $120 Million Fund To Support YIMBY

Bloomberg 1 hour ago

PUMSY
3 Growth Stocks That Could Help Make You a Fortune

The Trade Desk, Supermicro, and Palo Alto Networks all have plenty of room to grow.

Motley Fool 1 hour ago

PANW

TTD

SMCI
Nasdaq Correction: This Magnificent Stock Is a Rare Bargain

President Donald Trump launched tariffs on imports from Canada, China, and Mexico -- opening the door to rising prices that could hurt corporate earnings and the customer's wallet. As a result, benchmarks tumbled, and the Nasdaq even entered correction territory last week, falling more than 10% from its most recent high on Dec. 16. No one likes to see stocks tumble.

Motley Fool 1 hour ago

NVDA
Rheinmetall Annual Sales Soar to Record $10.65 Billion, But Miss Target

While 2024 sales grew 35%, boosted by increased demand, there was a dip in sales at its power systems and trade divisions at the start of of the year.

The Wall Street Journal 1 hour ago

RNMBF

RNMBY
Rheinmetall expects strong 2025 sales in Europe's 'era of rearmament'

BERLIN (Reuters) -Rheinmetall, a major beneficiary of Europe's renewed push to invest in defence, said on Wednesday it expects significant sales growth in 2025 and promised to update guidance after recent geopolitical developments are taken into account. The German defence company expects sales to grow by 25% to 30% in 2025 as a result of the Russian invasion of Ukraine and the decoupling of the United States from Europe, it said. At the same time, Europe's top ammunition maker anticipates an improvement in the operating result and an operating margin of around 15.5%, slightly above the 2024 level of 15.2%.

Reuters 2 hours ago

RNMBY
Stitch Fix Inc (SFIX) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth

Despite a decline in revenue and active clients, Stitch Fix Inc (SFIX) shows resilience with improved margins and strategic investments for future growth.

GuruFocus.com 2 hours ago

SFIX
Zara Parent Inditex Says Expansion Plan on Track Amid Fierce Competition in Fast Fashion

The owner of fashion brand Zara said store and online sales rose 4% at constant currency compared with the prior-year period.

The Wall Street Journal 2 hours ago

IDEXF

IDEXY
EU Hits Back as U.S. Steel and Aluminum Tariffs Take Effect

The 25% global levy was imposed by the Trump administration after the U.S. and Canada backed away from additional measures. The European Union responded with retaliatory tariffs.

The Wall Street Journal 2 hours ago

X
Kohl's Corp (KSS) Q4 2024 Earnings Call Highlights: Navigating Sales Declines and Strategic ...

Kohl's Corp (KSS) faces challenges with declining sales but remains focused on strategic brand and omnichannel improvements to drive future growth.

GuruFocus.com 2 hours ago

KSS
Hesai Group (HSAI) Q4 2024 Earnings Call Highlights: Record Lidar Shipments and Strong ...

Hesai Group (HSAI) reports robust growth in 2024 with over 500,000 Lidar units shipped and projects significant expansion in 2025.

GuruFocus.com 2 hours ago

HSAI
Roche Agrees to Develop Weight-Loss Therapy With Zealand Pharma

The companies agreed to share profits for the therapy equally in the U.S. and Europe, but Roche will have exclusive rights to commercialization in the rest of the world.

The Wall Street Journal 2 hours ago

RHHBF

RHHBY

RHHVF
Zara owner Inditex reports slower start to first quarter

ARTEIXO, Spain (Reuters) -Zara owner Inditex on Wednesday reported a slower start to its first quarter starting February 1 after full-year sales and profit met analysts' expectations, raising questions around its ability to keep building on rapid recent growth. Inditex's strong sales as Zara took market share from rivals such as H&M have driven a strong run in its share price, now more than double where it was three years ago, but the stock has struggled recently as concerns grow around weakening consumer demand. Sales were up just 4% in currency-neutral terms over the February 1 to March 10 period, Inditex said, compared to 11% growth a year ago.

Reuters 2 hours ago

ITX.MC
Roche secures Zealand obesity drug candidate for up to $5.3 billion

ZURICH (Reuters) -Roche has acquired rights to an obesity therapy by Denmark's Zealand Pharma in a collaboration deal worth up to $5.3 billion, as the Swiss drugmaker seeks to boost its prospects in the booming weight-loss market. The agreement covering the compound petrelintide, announced by Roche on Wednesday, marks renewed efforts to catch up with weight-loss market leaders Novo Nordisk and Eli Lilly. Under the accord, Zealand will receive $1.65 billion upfront with the possibility of milestone payments taking the total sum to $5.3 billion, depending mainly on phase 3 trials and sales development, Roche said.

Reuters 3 hours ago

ROG.SW

ZEAL.CO

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

(SNS9O.BA)

Related News

Meta is reportedly testing in-house chips for AI training

Teradyne stock plummeting after updating its guidance

Kohl's stock plummets as sales drop, guidance widely misses estimates amid turnaround efforts

Kohl's stock plunging on its cautious 2025 outlook: 3 takeaways

Should You Buy Advanced Micro Devices (AMD) Stock After Its 51% Drop?

Nvidia Is Down 26% From Its All-Time High -- Here's How Far It Can Fall, Based on Historic Precedent

The Nasdaq Just Hit Correction Territory: 2 Brilliant AI Stocks to Buy Now and Hold Forever

Puma Drops After Predicting a Tough Year for Sneaker Sales

3 Growth Stocks That Could Help Make You a Fortune

Nasdaq Correction: This Magnificent Stock Is a Rare Bargain

Rheinmetall Annual Sales Soar to Record $10.65 Billion, But Miss Target

Rheinmetall expects strong 2025 sales in Europe's 'era of rearmament'

Stitch Fix Inc (SFIX) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth

Zara Parent Inditex Says Expansion Plan on Track Amid Fierce Competition in Fast Fashion

EU Hits Back as U.S. Steel and Aluminum Tariffs Take Effect

Kohl's Corp (KSS) Q4 2024 Earnings Call Highlights: Navigating Sales Declines and Strategic ...

Hesai Group (HSAI) Q4 2024 Earnings Call Highlights: Record Lidar Shipments and Strong ...

Roche Agrees to Develop Weight-Loss Therapy With Zealand Pharma

Zara owner Inditex reports slower start to first quarter

Roche secures Zealand obesity drug candidate for up to $5.3 billion